About
A seasoned patent agent and accomplished research scientist.
• 18 years of large and small pharma industry experience in intellectual property support for new product development, licensing and acquisition opportunities.
• Direct experience in creating or expanding, evaluating, and defending the intellectual property related to biopharmaceuticals; mining discovery research activities for patentable inventions; design around strategies; and preparing new cases.
• Able to provide insight and input to strategic marketing using competitor IP and other business information.
• Experienced in interpreting and enforcing IP policy.
• Knowledge areas: cancer and metastasis, inflammatory mechanisms, enzymes and proteases, coagulation and complement pathways, radiation biology and nutrition.
• Specific experience with monoclonal antibodies and non-antibody scaffolds, bioconjugates (e.g. ADC), bioprocesses, immunoliposomes, analytic methods for selecting or ranking biophysical properties, biomarkers useful for patient or treatment identification or monitoring, miRNA, and molecular vaccines.
• Studied human metabolism and pharmacology.
Writing is my passion and consolidating and organizing scientific information into clearly presented documents is my gift.
Work history
Bio PA NJ DE, Patent Agent
Phila Main Line, Consultant/Advisor
Patent professional helping individual inventors, small and large companies position intellectual assets for optimized monetization. Specific experience in patent preparation, patent searching and analysis: patentability, right to use, patent term, patent landscapes for biotechnology, biologics, antibody and targets. Patent strategy related to business or licensing objectives and portfolio audits, Patent marking and patent licensing.
Centocor, Patent Agent, Johnson & Johnson, Patent Law Group
Patenting and IP licensing: patentability, right-to-use, patent preparation and prosecution. Supported new product development, and evaluated licensing and acquisition opportunities in the field of monoclonal antibodies and related molecules and technology platforms for targeted biopharmaceuticals. Provided insight and input to strategic marketing on competitor IP.
Omnicom Group, Director, Competitive Tech Intel & IP at QED Technologies
Conducted competitor and IP searches for licensing opportunities. Patent audits, patent portfolio development and strategy for small and start-up companies. Malvern based QED Technologies was acquired by Omnicom in 2000.
Zynaxis, Inc., Director, Biology
Managed 8 biologists conducting proof-of-concept studies on bioconjugates designed for local slow release of chemotherapy for treatment of solid tumors. Established or monitored external collaborations. Activities related to patenting, publishing and public disclosures.
Stanford University Medical Center, Post-Doc
Associate with Prof Martin Brown in the Cancer Biology Research Laboratory. Discovered the mechanism of action of tirapazamine. Investigation of relationship between thiol oxidation and DNA damage repair.
Peace Corps, Biology Teacher, Ghana Secondary Schools
Taught Form 4-6B at Tamale Secondary School
Education and qualifications
Stanford University School of Medicine Post-Doc, Cancer Biology and Radiation Oncology
University of California, Davis Ph.D., Nutrition, Pharmacology, Physiological Chemistry
Columbia University College of Physicians and Surgeons M.S., Human Nutrition
University of California, Berkeley A.B., Biochemistry
Coursera ,
Coursera ,
